Showing 1791-1800 of 7383 results for "".
Improving Treatment Capabilities for Vitiligo
https://practicaldermatology.com/series/c-suite-chats/improving-treatment-capabilities-for-vitiligo/29745/David Domzalski, CEO and President of Vyne Therapeutics, discusses what makes vitiligo difficult to treat and how his company is working to address those challenges.Health Disparities and Skin Cancer In People of Color
https://practicaldermatology.com/topics/skin-of-color/health-disparities-and-skin-cancer-in-people-of-color/22986/Skin cancer diagnosis and treatment may be delayed in people of color, contributing to poor prognosis.It's Time to Get Serious About Scalp Psoriasis Treatment
https://practicaldermatology.com/topics/practice-management/its-time-to-get-serious-about-scalp-psoriasis-treatment/20545/Largely due to adherence issues, topical treatments don't work for many scalp psoriasis patients.Skin Cancer 2024: Trends, Updates, and What’s Next
https://practicaldermatology.com/columns/skin-cancer-updates/skin-cancer-2024-trends-updates-and-whats-next/24214/Corey Hartman, MD, FAAD, talks about trends and issues to watch in 2024 in the subspecialty of skin cancer.Finding Influencers to Promote Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/finding-influencers-to-promote-your-dermatology-practice/23757/Influencer marketing is not simply a form of paid advertisement; it is based on a mutually beneficial partnership.Considering Going Direct Pay?
https://practicaldermatology.com/topics/practice-management/considering-going-direct-pay/23552/A dermatologist shares thoughts on what “direct care” really means.Total Body Skin Exams: Don't Abandon Them
https://practicaldermatology.com/topics/skin-cancer-photoprotection/total-body-skin-exams-dont-abandon-them/20628/Lesion-directed exams may save time, but is the limited temporal savings worth it?Anti-OX40 Ligand Antibody Trials
https://practicaldermatology.com/series/updates-atopic-dermatitis/anti-ox40-ligand-antibody-trials/29531/Lead study author Stephan Weidinger, MD, PhD, Director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein, discusses the phase 2b STREAM-AD trial, evaluating amlitelimab in adult patients with moderate-to-severe atopic dermatitis.UV Risks, Cosentyx Update, ASDS Honorees
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-uv-risks-cosentyx-update-asds-honorees/18623/Teen indoor tanning may be linked with alcohol consumption in the past 30 days, marijuana use, and lifetime use of select illicit drugs, according to findings in JAMA Dermatology. L'Oréal unveiled My UV Patch this month at the Consumer Electronics Show. The stretchable skin sensor, to be introducedThe Placebo and Nocebo Effects in Dermatology
https://practicaldermatology.com/columns/clinical-focus-1/the-placebo-and-nocebo-effects-in-dermatology/23559/Increasing evidence suggests that these effects—though not fully understood—may be harnessed for patient care.